CMI_LatestReportOrientedBlogs

Anhydrous Dibasic Calcium Phosphate Market Anhydrous Dibasic Calcium Phosphate is a calcium phosphate compound mainly used as a food additive and dietary supplement. It is commonly used as a leavening agent in baking powder to induce the chemical reaction that causes baked goods to rise. Being odorless, tasteless and chemically inert, it is considered a safe additive. The compound is widely utilized in the pharmaceutical industry to manufacture calcium supplements and as an excipient in several drug formulations. It helps maintain electrolyte balance and supports bone and teeth health. The growing concerns regarding bone health issues and dietary deficiencies have increased the demand for Anhydrous Dibasic Calcium Phosphate supplements globally. The global Anhydrous Dibasic Calcium Phosphate market is estimated to be valued at US$ 245.96 billion in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period of 2024 to 2030. Key Takeaways Key players operating in the A

  Pharma 4.0 Market Pharma 4.0 refers to the digital transformation of various pharmaceutical processes and business operations with technologies like artificial intelligence, IoT, blockchain, 3D printing and others. These technologies enable faster drug discovery and development, improve supply chain operations, enhance patient engagement and safety. Pharma companies are increasingly adopting digital tools to streamline clinical trials by enrolling more volunteers, accelerating drug approvals and better monitoring drug supplies. The global Pharma 4.0 Market is estimated to be valued at US$ 16.75 Bn in 2024 and is expected to exhibit a CAGR of 18.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rapid adoption of digital technologies like AI, IoT and 3D printing in the pharmaceutical industry has helped accelerate innovation and streamline operations significantly. As pharma companies digitally tra

Nutraceutical Excipient Market Nutraceutical excipients are additives and processing aids used in the manufacturing and delivery of functional foods and dietary supplements. They are used to encapsulate, protect from degradation, enhance absorption, and aid delivery of ingredients such as vitamins, minerals, Omega-3, and probiotics. The rising demand for functional foods and beverages enriched with a variety of nutrients is driving the need for innovative excipients for efficient encapsulation and delivery. The global Nutraceutical Excipient Market is estimated to be valued at US$ 3,087.7 Bn in 2024 and is expected to exhibit a CAGR of 3.4% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving growth in the nutraceutical excipient market is the rising demand for functional foods enriched with nutrients and probiotics. Excipients play a vital role in microencapsulating sensitive in

Pharmaceutical Industry Market India and Oman pharmaceutical industry market has witnessed robust growth riding on affordable medications demand. Generic drugs are affordable versions of brand-name drugs that have the same intended use, dosage, effects, risks, safety, strength, and quality. Generic drugs account for around 75%-80% of the total pharma sales in India as they provide cost-effective treatment options to a huge patient pool. The growing incidence of chronic diseases and rising healthcare expenditure in India and Oman have accelerated generic drugs demand. India and Oman Pharmaceutical Industry Market is estimated to be valued at US$ 45 Billion in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing generic drugs demand has been a key growth driver for India and Oman pharmaceutical industry market. Generic drugs have significantly low

Pancreatic Cancer Therapeutics and Diagnostic Market The Pancreatic Cancer Therapeutics and Diagnostic Market is estimated to be valued at US$ 4255.87 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: This market consists of therapeutic and diagnostic products related to pancreatic cancer. Pancreatic cancer most commonly involves tumors that start in the exocrine cells or the tissues that produce pancreatic juices. The leading treatments include chemotherapy, radiation therapy, targeted therapy, immunotherapy and surgery. Market key trends: One of the key trends fuelling the market growth is rising prevalence of pancreatic cancer. Pancreatic cancer is one of the deadliest cancers, as it is often detected at an advanced stage when it is difficult to treat. According to Global Cancer Observatory, in 2020, over 494,000 new cases of pancreatic cancer were diagn

Estrogen Blockers Market The Estrogen Blockers Market is estimated to be valued at US$ 15.02 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Estrogen blockers, also known as antiestrogens, are a class of drugs used primarily in hormone therapy for breast cancer and prevention of breast cancer in high-risk individuals. They work by blocking the effects of estrogen in the body. Common estrogen blockers include Tamoxifen, Toremifene, Fulvestrant and Exemestane. They produce negative feedback inhibition of estrogen receptors in breast tissue and other target organs to reduce the growth stimulatory effects of estrogen on breast cancer cells. Market Dynamics: Growing incidence of hormone-related cancers such as breast cancer is a key factor driving the growth of estrogen blockers market. According to the statistics provided by WHO, breast cancer is the most

cryptoxanthin market The global cryptoxanthin market is estimated to be valued at US$ 740 million in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Cryptoxanthin is a type of carotenoid pigment found in various fruits and vegetables, such as oranges, red peppers, and persimmons. It is known for its antioxidant properties and has been gaining popularity in the nutraceutical and functional food industries. The increasing awareness about the health benefits of cryptoxanthin, such as its ability to boost immunity, reduce inflammation, and protect against chronic diseases, is driving the demand for cryptoxanthin-based products in the market. The rising trend of consumers adopting a healthy lifestyle and seeking natural and organic alternatives for supplements and food additives is further fueling the market growth for cryptoxanthin. Market Key Trends: One key trend

  Insulin Sensitizers Market The global Insulin Sensitizers market is estimated to be valued at US$ 15.09 billion in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period. This growth can be attributed to two major drivers - the increasing prevalence of diabetes and the rising research and development activities in the healthcare sector. Market Overview: Insulin sensitizers are drugs that help improve the body's response to insulin, thus reducing insulin resistance. These drugs are primarily used in the treatment of type 2 diabetes. They work by lowering blood sugar levels, reducing the risk of cardiovascular diseases, and improving overall insulin sensitivity in the body. Market Dynamics: 1. Driver 1: Increasing Prevalence of Diabetes The global prevalence of diabetes is on the rise, primarily due to sedentary lifestyles, unhealthy dietary habits, and an aging population. According to the International Diabetes Federation, approximately 463 million peopl

  U.S. Sucralfate Market The U.S. sucralfate market is estimated to be valued at US$ 296.2 million in 2017 and is expected to exhibit a CAGR of 3.1% over the forecast period 2018–2026, as highlighted in a new report published by Coherent Market Insights. Market Overview: Sucralfate is a medication used to treat and prevent gastric ulcers. It forms a protective coating over the ulcers, allowing them to heal and preventing further damage. Sucralfate is commonly prescribed to patients with gastric ulcers caused by long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) or Helicobacter pylori infection. The market for sucralfate in the U.S. is driven by the increasing prevalence of gastric ulcers, especially among the geriatric population. According to the American College of Gastroenterology, gastric ulcers affect approximately 6 million Americans every year. Market Dynamics: 1. Increasing Prevalence of Gastric Ulcers: The rising prevalence of gastric ulcers, particularly a

  India Immuno-Oncology Drugs Market The India Immuno-Oncology Drugs Market is estimated to be valued at US$265 Mn in 2022 and is expected to exhibit a CAGR of 13.1% over the forecast period of 2021 to 2028, as highlighted in a new report published by Coherent Market Insights. Market Overview: The India Immuno-Oncology Drugs Market refers to the use of immunotherapy in the treatment of cancer. Immunotherapy is a revolutionary approach that harnesses the body's immune system to fight against cancer cells. It has gained significant attention in recent years due to its potential to provide long-term remission and improve overall survival rates in cancer patients. Key products associated with this market include immune checkpoint inhibitors, monoclonal antibodies, cancer vaccines, and adoptive cell transfer therapy. Market Dynamics: 1. Increasing Prevalence of Cancer: Cancer is a major healthcare burden in India, with a high incidence of various types of cancer. According to th

  Nutritional Supplements Market The Germany Nutritional Supplements Market is estimated to be valued at US$ 4,601.9 Mn in 2020 and is expected to exhibit a CAGR of 3.8% over the forecast period 2021 to 2028, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: The Germany Nutritional Supplements Market consists of various products that are designed to provide essential nutrients to individuals. These supplements include vitamins, minerals, herbal extracts, amino acids, and other dietary substances. They are consumed to enhance overall health, support specific body functions, and prevent nutritional deficiencies. The market includes products in various forms such as tablets, capsules, powders, liquids, and gummies. Nutritional supplements are widely used in Germany to address specific health concerns, improve athletic performance, and promote overall well-being. B) Market Dynamics: 1. Increasing Health Awareness: The growing focus on preven

  Pruritus Therapeutics Market The global Pruritus Therapeutics market is estimated to be valued at US$ 7.9 billion in 2021 and is expected to exhibit a CAGR of 3.6% over the forecast period 2022-2031, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Pruritus, also known as itchiness, is a common symptom associated with various skin disorders such as eczema, psoriasis, hives, and dermatitis. It can be caused by allergic reactions, infections, drug reactions, and other underlying medical conditions. Pruritus therapeutics are drugs or therapies that help in alleviating itchiness and providing relief to patients suffering from pruritus. These therapeutics include topical creams, oral medications, phototherapy, and other treatment options. B) Market Dynamics: 1. Driver One: Increasing Research and Development Activities The market is driven by the increasing focus on research and development activities by pharmaceutical companies to develo

  PARP Inhibitor Market The global PARP Inhibitor Market is estimated to be valued at USD 6.60 billion in 2022 and is expected to exhibit a CAGR of 13.09% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: PARP inhibitors are a class of drugs that inhibit the activity of Poly (ADP-ribose) polymerase (PARP) enzymes in the body. These enzymes play a crucial role in repairing damaged DNA in cells. By inhibiting PARP, these drugs prevent cancer cells from repairing their DNA, thus leading to their death. PARP inhibitors have shown great promise in the treatment of various types of cancer, including breast, ovarian, and prostate cancer. B) Market Dynamics: The PARP inhibitor market is driven by two key factors: 1. Increasing Incidence of Cancer: The growing prevalence of cancer worldwide is a major driver for the PARP inhibitor market. According to the World Health Organization (WHO), cancer is the second lead

  Pharmacovigilance Market Pharmacovigilance, as an integral part of the healthcare ecosystem, plays a pivotal role in ensuring the safety and efficacy of pharmaceutical products worldwide. The Pharmacovigilance Market Dynamics are constantly evolving, influenced by several key factors such as advancements in medical research, changing regulatory landscapes, and increasing awareness among healthcare professionals and patients. One of the significant drivers behind the growth of the global pharmacovigilance market is the rising prevalence of adverse drug reactions (ADRs) and their potential impact on patient safety. As drug therapies become more complex and personalized, the likelihood of encountering unexpected side effects increases. Pharmacovigilance systems are essential for the timely detection, assessment, and management of these adverse events to minimize harm and enhance drug safety. A Study by Coherent Market Insights, The Global Pharmacovigilance Market was valued at US$

  Alopecia Treatment Market Alopecia , commonly known as hair loss, is a medical condition that affects millions of people worldwide. It can have a profound impact on individuals, both physically and emotionally, leading to a significant demand for effective treatment options. As a result, the alopecia treatment market has witnessed substantial growth over the years. This article aims to assess the economic impact of the alopecia treatment market, examining its contributions to various sectors, including healthcare, pharmaceuticals, research and development, and the overall economy. The alopecia treatment market plays a vital role in the healthcare sector, encompassing various healthcare providers, including dermatologists, trichologists, and primary care physicians. These healthcare professionals diagnose and treat patients with alopecia, leading to increased healthcare expenditure related to consultations, diagnostic tests, and ongoing treatments. A Study By Coherent Market Insig